It’s been a tumultuous 18 months since the passage of Medicare drug price negotiations punctured the lobbying group’s aura of invincibility. Is it time for a policy revamp at PhRMA?
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,